SCHEMBL25833558

SCHEMBL25833558

CCc1ccc2[nH]c(C(C)C)nc2n1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
ADORA2B P29275 1/20 0.36
TACR2 P21452 1/20 0.33
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
GSK3B P49841 1/20 0.31
ALOX15 P16050 1/20 0.31
PRMT5 O14744 3/20 0.30
MLKL Q8NB16 1/20 0.30
DDAH1 O94760 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10140811 0.78 HSD17B10 (0.43) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL10118778 0.78 HSD17B10 (0.43) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL22533975 0.76 PRMT5 (0.42) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL29424830 0.76 PRMT5 (0.42) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL12231815 0.76 DDAH1 (0.48) ADORA3ADORA2AADORA1HTTDDAH1
SCHEMBL12232006 0.74 KDM4E (0.40) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL29543491 0.72 KDM4E (0.39) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL12810051 0.72 HSD17B10 (0.36) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL22533874 0.70 CHEK2 (0.46) HSD17B10KDM4ELMNAALDH1A1HPGD
SCHEMBL805162 0.69 NUDT1 (0.55) HSD17B10KDM4ELMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA HSD17B10 1268/4885KDM4E 4219/4885LMNA 2015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.